<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="https://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="https://www.loc.gov/MARC21/slim https://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="https://www.loc.gov/MARC21/slim">

  <leader>01477nam a2200241   4500</leader>
  <controlfield tag="001">392655</controlfield>
  <datafield tag="010" ind1=" " ind2=" ">
    <subfield code="a">9789291687398</subfield>
  </datafield>
  <datafield tag="090" ind1=" " ind2=" ">
    <subfield code="a">392655</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">20140715d2014       y0pory50      ba</subfield>
  </datafield>
  <datafield tag="101" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="200" ind1=" " ind2=" ">
    <subfield code="a">General report of activities 2013</subfield>
    <subfield code="e">key achievements and governance</subfield>
    <subfield code="e">a year in review</subfield>
  </datafield>
  <datafield tag="210" ind1=" " ind2=" ">
    <subfield code="a">Luxembourg</subfield>
    <subfield code="c">Publications Office of the European Union</subfield>
    <subfield code="d">2014</subfield>
  </datafield>
  <datafield tag="215" ind1=" " ind2=" ">
    <subfield code="a">104 p.</subfield>
    <subfield code="d">30 cm</subfield>
  </datafield>
  <datafield tag="330" ind1=" " ind2=" ">
    <subfield code="a">Foreword. Introduction. Part I - Report of activities: Key achievements and governance. Chapter 1 - Executive summary; Chapter 2 - Core business: monitoring and reporting on the drugs problem in Europe; Chapter 3 - Cooperation and collaboration with key partners; Chapter 4 - Supporting the achievement of results; Part II - Chapter 5 - Characteristics and nature of EMCDDA management and internal control systems; Chapter 6 - Assessment and improvement of management and internal control systems; Chapter 7 - Declaration of assurance by Authorising Officer and Management Board's analysis and assessment of the Authorising Officer's General Report of Activities for the financial year 2013. Annexes.</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">RELAT&#xD3;RIO ANUAL</subfield>
    <subfield code="9">299235</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">COMBATE &#xC0; DROGA</subfield>
    <subfield code="9">410441</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">EMCDDA</subfield>
    <subfield code="9">324041</subfield>
  </datafield>
  <datafield tag="710" ind1=" " ind2=" ">
    <subfield code="a">EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION</subfield>
    <subfield code="9">351987</subfield>
  </datafield>
  <datafield tag="955" ind1=" " ind2=" ">
    <subfield code="x">Oferta</subfield>
  </datafield>
  <datafield tag="995" ind1=" " ind2=" ">
    <subfield code="1">0</subfield>
    <subfield code="4">PJ_22_000000000000000_C_105</subfield>
    <subfield code="5">2022-06-06</subfield>
    <subfield code="6">PJ34575</subfield>
    <subfield code="9">424961</subfield>
    <subfield code="a">PJ</subfield>
    <subfield code="c">PJ</subfield>
    <subfield code="f">PJ134575</subfield>
    <subfield code="k">PJ22.C.105</subfield>
    <subfield code="n">2022-06-06</subfield>
    <subfield code="o">0</subfield>
    <subfield code="r">MO</subfield>
    <subfield code="x">Oferta</subfield>
  </datafield>
</record>
